AsCITEs reinfusion has been practised for many years. One effect of such treatment is to expand the plasma volume which may result in an improvement of renal function. A problem with ascites reinfusion has been the large intravenous fluid load that the patient receives. In conjunction with Rh6ne-Poulenc an apparatus has therefore been developed in which the ascitic fluid is first passed through a haemodialysis membrane, so that the protein of the fluid can be concentrated by ultrafiltration, before reinfusing (Levy et al., 1971). In this way excessive water and electrolytes can be discarded.
patients, most of them having longstanding ascites refractory to diuretic treatment.
The advantages of this method of treatment are its rapidity and efficacy, ascites being reduced in a mean time of 21±13 hr. Hyponatraemia is easily corrected by a sodium load during reinfusion. There was improvement in renal function in 11 of 37 cases. Adverse effects are fever, pulmonary oedema, peritoneal infections and coagulation disorders. Ascites recurred in 84 % of the cases, but the procedure shortens hospital stay and reduces the cost of the treatment.
AsCITEs reinfusion has been practised for many years. One effect of such treatment is to expand the plasma volume which may result in an improvement of renal function. A problem with ascites reinfusion has been the large intravenous fluid load that the patient receives. In conjunction with Rh6ne-Poulenc an apparatus has therefore been developed in which the ascitic fluid is first passed through a haemodialysis membrane, so that the protein of the fluid can be concentrated by ultrafiltration, before reinfusing (Levy et al., 1971) . In this way excessive water and electrolytes can be discarded.
Patients
Two hundred and ten patients have been treated with 318 reinfusions. The underlying pathology was as follows: alcoholic cirrhosis (155 cases), posthepatic cirrhosis (thirty-one), biliary cirrhosis (two), Budd-Chiari syndrome (seven), abdominal tumours (seven), pancreatitis (one), constrictive pericarditis (one) and miscellaneous (six).
At the time of reinfusion renal function was often poor, in ninety-eight instances the plasma urea concentration being greater than 50 mg/100 ml, and in fourteen greater than 150 mg/100 ml. In the most dramatic case the reinfusion was continued for 64 hr and 28 1 of filtrate removed. In the same patient another reinfusion was performed 4 months later which lasted 91 hr. Thirty-eight litres of filtrate were removed and the patient also passed 24-3 1 of urine containing 2465 mEq of sodium.
Reinfusion and hyponatraemia
Plasma sodium concentration often fell 7 days after reinfusion (Fig. 1 ). This could be prevented by giving a sodium load during the reinfusion. The High sodium load (twentynine cases), low sodium load (nineteen cases), ---; without sodium (twenty-four cases), amount of sodium given was calculated on the basis of body weight and it was found that 0 7 mEq of sodium/kg body weight are needed to increase plasma sodium concentration by 1 mEq/l. Excessive potassium loss resulting in hypokalaemia did not occur.
Reinfusion and renal failure
In patients with functional renal failure, one might expect renal function to improve secondary to the increase in plasma volume. The results, however, were disappointing. Thirty-seven patients with a plasma urea concentration greater than 80 mg/100 ml were so treated. In only eleven cases was there a marked improvement in renal function. In eight cases renal function deteriorated.
Adverse effects
Pyrexia occurred in 50 % of reinfusions, but this disappeared soon afterwards. Pulmonary oedema developed in twelve cases and haemolytic jaundice in two.
Overt gastrointestinal haemorrhage occurred in eleven cases. Laboratory changes in coagulation factors were much more frequent (Table 1) , and clinical manifestations of fibrinolysis or intravascular coagulation were present in eight cases, but these were controlled in all but one patient with ¢-amino caproic acid (Buffet et al., 1973) . Peritoneal infection appeared to be a consequence of the procedure in fourteen cases, and this was a major factor in contributing towards death in five. Bacterial growth on the catheter tip was observed in nineteen instances.
Serious mechanical incidents were relatively rare, but included perforated sigmoid diverticulum (two cases), strangulated umbilical hernia (three), rupture of epigastric artery (one), and a fatal subclavian haematoma (one). Minor mechanical adverse effects were common but never serious, e.g. phlebitis, loss of fluid into the abdominal wall, scrotal oedema, pain, and transient ileus.
Long term value
Ascites reinfusion in no way corrects the liver disease or the factors leading to ascites formation. Its value is therefore only palliative. However, of 150 patients treated up to 1 January 1974 seventy-two are still alive, in most cases the ascites being controlled by diuretics, but some' patients have had repeated reinfusions (one case receiving nine). The causes of death in the other seventy-eight cases were liver failure (twenty-one cases), renal failure (twentyone), hepatoma (seven), haemorrhage (fifteen), and others (fourteen). 
